Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are important conditions which often coexist. Higher rates of comorbidities among people with asthma-COPD overlap (ACO) may complicate clinical management. The aim of this study was to determine the prevalence of 30 different comorbidities and to analyze associations between these comorbidities and physical activity (PA) in Spanish people with ACO. Cross-sectional data from the Spanish National Health Survey 2017 were analyzed. A total of 198 Spanish people with ACO aged 15–69 years (60.6% women) were included in this study. PA was measured with the International Physical Activity Questionnaire (IPAQ) short form. Diagnosis of chronic conditions were self-reported. Associations between PA and comorbidities were analyzed using multivariable logistic regression models. The most prevalent comorbidities were chronic allergy (58.1%), chronic lumbar pain (42.4%), chronic cervical pain (38.4%), hypertension (33.3%) and arthrosis (31.8%). A PA level lower than 600 MET·min/week was significantly associated with urinary incontinence (OR = 3.499, 95% CI = 1.369–8.944) and osteoporosis (OR = 3.056, 95% CI = 1.094–8.538) in the final adjusted model. Therefore, the potential influence of PA on reducing the risk of these conditions among people with ACO should be considered, not only because of the health benefits, but also because PA can contribute to a more sustainable world.
Highlights
The Forum of International Societies (FIRS) established chronic obstructive pulmonary disease (COPD) and asthma as two of the five major respiratory diseases [1]
A physical activity (PA) level lower than 600 MET·min/week was significantly associated with urinary incontinence (OR = 3.499, 95% confidence intervals (CI) = 1.369–8.944) and osteoporosis (OR = 3.056, 95% CI = 1.094–8.538) in the final adjusted model
This study revealed that the vast majority of Spanish people with Asthma-COPD overlap (ACO) have comorbidities, with a 93.9% suffering from at least one comorbidity
Summary
The Forum of International Societies (FIRS) established chronic obstructive pulmonary disease (COPD) and asthma as two of the five major respiratory diseases [1]. Both conditions are important public health problems based on their high prevalence, socioeconomic burden and morbimortality [2,3]. COPD was accountable for 5.8% of global deaths in 2019 and asthma 0.82% [4] Both diseases result in a high socioeconomic burden [5,6]. These respiratory conditions are characterized by airflow limitation and respiratory symptoms, but there are differences between them that need to be noted.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
